TOBAM’s Puma Biotechnology PBYI Stock Holding History

TOBAM’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-318,384	Closed	-$24M	–	131
2015 Q3	$24M	Buy	318,384 +239,304	+303%	+$22.6M	0.94%	38
2015 Q2	$9.23M	Buy	+79,080	New	+$14.3M	0.34%	69

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TOBAM's PBYI Position: Q4 2015 in Review

TOBAM sold out of Puma Biotechnology (PBYI) in Q4 2015, closing a stake of 318,384 shares — an estimated $24M sold.

TOBAM first reported a position in PBYI in Q2 2015 and held it in 2 quarters. The position peaked at $24M in Q3 2015. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2015.

TOBAM reported no remaining Puma Biotechnology position as of Q4 2015 after selling out during the quarter.
TOBAM sold 318,384 Puma Biotechnology shares in Q4 2015, an estimated $24M.
TOBAM first reported a position in Puma Biotechnology in Q2 2015 and held it in 2 quarters.
TOBAM's Puma Biotechnology position peaked at $24M in Q3 2015.
133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2015.

Based on TOBAM's 13F filing for Q4 2015, filed 16 Feb 2016.